Curis | CRIS - Trade Creditors


Curis reported $6.74M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
Alaunos Therapeutics USD 400K 213K Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
AstraZeneca USD 22.89B 388M Jun/2026
Bayer EUR 6.59B 496M Mar/2026
Bristol-Myers Squibb USD 4.16B 76M Jun/2026
CSL USD 3.17B 290M Dec/2025
Curis USD 6.74M 1.13M Mar/2026
Eli Lilly USD 5.03B 350M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
Incyte USD 1.39B 1.16B Jun/2026
Merck USD 3.86B 541M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
Takeda JPY 446.78B 44.56B Jun/2026
TG Therapeutics USD 148.84M 41.34M Mar/2026
Verastem USD 9.6M 2.85M Mar/2026